Immuneering Corp (IMRX)
2.11
+0.07
(+3.43%)
USD |
NASDAQ |
Nov 21, 16:00
2.12
+0.01
(+0.47%)
Pre-Market: 09:15
Immuneering Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 49.60% |
| June 30, 2022 | 49.23% |
| March 31, 2022 | 50.55% |
| December 31, 2021 | -8.77% |
| September 30, 2021 | 54.56% |
| June 30, 2021 | 51.73% |
| Date | Value |
|---|---|
| March 31, 2021 | 45.31% |
| December 31, 2020 | 28.85% |
| September 30, 2020 | 53.85% |
| June 30, 2020 | 50.70% |
| March 31, 2020 | 47.21% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-8.77%
Minimum
Dec 2021
54.56%
Maximum
Sep 2021
42.98%
Average
49.60%
Median
Sep 2022
Gross Profit Margin (Quarterly) Benchmarks
| Singular Genomics Systems Inc | -74.14% |
| Biomarin Pharmaceutical Inc | 74.73% |
| Integra Lifesciences Holdings Corp | 52.58% |
| Eton Pharmaceuticals Inc | 61.04% |
| Tenon Medical Inc | 47.13% |